spacer
home > ict
PUBLICATIONS

International Clinical Trials

 
International Clinical Trials (ICT) is a specialist journal designed to provide global coverage of
key topics pertinent to the clinical trials sector.

Published quarterly, and edited by Dr Graham Hughes, the journal offers a platform of
communication and information-sharing for executive and strategic decision makers, seeking
out new trends and marketing opportunities, as well as putting a spotlight on the latest innovations coming to market. ICT is specifically designed to be of interest to those actively seeking to source services for improved efficiency in what is an increasingly competitive market.

Prompted by the synergies between trial operations and wider contract research and outsourcing
issues, ICT joined forces with sister title European Pharmaceutical Contractor (EPC) in late-2015,
in a move that brings added value to both brands. With EPC now an inserted edition within ICT,
industry practitioners across these complementary subject areas now have unrivalled access
to a wealth of shared views and analyses.

 
For further information please contact:

Advertising
Louise White

Editorial
Joel Emmons

Connect with us on Twitter: follow @IntClinTrials

Read our publications on the go in the Samedan app for phones and tablets. You can download issues for offline reading, and our archives go as far back as 2008! Download for free on the App Store, GooglePlay, or Amazon.

   
 


Click here to view the digital version of ICT


 


  Click here to view the digital version of Medical Writing:
The Backbone of Clinical Development
 
 

 

ict
 
 
Featured in this issue
Clinical Trial Supply & Packaging
Adaptive Trial Designs

Redefining the Gold Standard

Detailing the process of a trial is pivotal to its success, and developing an adaptive trial can improve the outcome. However, there can be complications to this method, as demonstrated by Dr Chitra Lele and Dr Ritu Budania at Sciformix.

  Clinical Trial Supply & Packaging
Trial and No Error

The Evolution of Environmental Monitoring

Jukkapekka ‘JP’ Asikainen and Ossi Laakkonen at Sensire discuss the technicalities and subtleties of the technologies available to improve clinical trial supply and how best to select one. 



spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August, and November



 

Industry Events

BioTrinity 2019

30 April - 1 May 2019, etc.venues 155 Bishopsgate, London EC2M 3YD

BioTrinity 2019 is taking place from the 30th April – 1stMay at etc.venues 155 Bishopsgatein London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering and Investment conference in Europe, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.
More info >>

 
News and Press Releases

Packline Materials Handling Announce The Production Of The New Clamp Attachment With Narrow Rollers And Extended Reach For Handling Rolls.

New to Packline Materials Handling is the clamp attachment with motorised rotation, narrow rollers and extended reach, designed to load and unload rolls of film or foil from a pallet and load them into a wrapping machine. This roll handling solution is suitable for food processing and pharmaceutical industries.
More info >>

air transport logo

 

White Papers

Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services

DrugDev

With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement